1. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol. 2004; 5:136–146.
2. Houston CS, Dickinson J. Cerebral form of high-altitude illness. Lancet. 1975; 2:758–761.
3. Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001; 345:107–114.
4. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, et al. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab. 2006; 26:99–111.
5. Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol. 1987; 72:236–239.
6. Hassel B, Boldingh KA, Narvesen C, Iversen EG, Skrede KK. Glutamate transport, glutamine synthetase and phosphate-activated glutaminase in rat CNS white matter. A quantitative study. J Neurochem. 2003; 87:230–237.
7. Kang EG, Jeon SJ, Choi SS, Song CJ, Yu IK. Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol. 2010; 31:559–564.
8. Gutierrez LG, Rovira A, Portela LA, Leite Cda C, Lucato LT. CT and MR in non-neonatal hypoxic-ischemic encephalopathy: radiological findings with pathophysiological correlations. Neuroradiology. 2010; 52:949–976.
9. Kim YH, Foo M, Terry RD. Cyanide encephalopathy following therapy with sodium nitroprusside: report of a case. Arch Pathol Lab Med. 1982; 106:392–393.
10. Hackett PH, Yarnell PR, Weiland DA, Reynard KB. Acute and evolving MRI of high-altitude cerebral edema: microbleeds, edema, and pathophysiology. AJNR Am J Neuroradiol. 2019; 40:464–469.